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An Integrative Disease Information Network
Approach to Similar Disease Detection
Wuli Xu, Lei DuanB, Huiru Zheng, Jesse Li-Ling, Weipeng Jiang, Yidan Zhang, Tingting Wang, Ruiqi Qin
Abstract—Disease similarity analysis impacts significantly in pathogenesis revealing, treatment recommending, and disease-causing
genes predicting. Previous works study the disease similarity based on the semantics obtaining from biomedical ontologies (e.g.,
disease ontology) or the function of disease-causing molecules. However, such methods almost focus on a single perspective for
obtaining disease features, which may lead to biased results for similar disease detection. To address this issue, we propose a disease
information network-based integrate approach named MISSION for detecting similar diseases. By leveraging the associations between
diseases and other biomedical entities, the disease information network is established firstly. And then, the disease similarity features
extracted from the aspects of disease taxonomy, attributes, literature, and annotations are integrated into the disease information
network. Finally, the top-k similar disease query is performed based on the integrative disease information. The experiments conducted
on real-world datasets demonstrate that MISSION is effective and useful in similar disease detection.
Index Terms—similar disease detection, disease information network, multimodal-information
F
1 INTRODUCTION
Similar disease detection has a wide range of biomed-
ical applications, such as disease classification [1], patho-
genesis understanding [2], disease-causing molecules in-
ference [3], therapeutic drug prediction [4], and clinical
decision-making systems improvement [5]. For a pair of
diseases, multiple types of relationships can be employed
to measure the similarity. For example, the “disease-gene-
disease” relationship is used to find diseases sharing iden-
tical disease-causing genes. And the “disease-phenotype-
disease” relationship is used to find diseases having similar
symptoms.
In general, similar disease detection methods can be
divided into the following two categories:
• Homogeneous relationship based: some studies focus
on using a specific relationship to discover similar
diseases. For example, Wang et al. [6] measured the
disease similarity on the aspect of term semantics
through the “disease-term-disease” relationship ob-
tained from Disease Ontology (DO) [7]. Mathur et
al. [8] measured the similarity between diseases on
the aspect of the “disease-gene-disease” relationship
retrieved from Gene Ontology (GO) [9]. Clearly, the
results of similar disease detection depend on the
selection of similar relationships. However, it is not
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easy to select a suitable similar relationship unless
the available domain knowledge is enough.
• Heterogeneous relationships based: some studies con-
sider the disease similarity by combining multiple
similar relationships. For example, Qin et al. [10]
provided a disease information network (DIN) con-
structed by multiple disease relationships to perform
similar disease detection. Cheng et al. [11] com-
bined the “disease-gene-disease” relationship (i.e.,
disease-causing gene functions) with the “disease-
term-disease” relationship (i.e., disease term seman-
tics) to measure the disease similarity.
Clearly, it’s more flexible to consider heterogeneous re-
lationships, compared with homogeneous ones, for similar
disease detection. DIN [10] includes multi-type disease-
related entities (nodes) and relationships (edges). As a re-
sult, it can provide a comprehensive perspective on disease
information.
It’s worth noting that the disease-related information
in the DIN is structured. In other words, the semantic
of any path in the DIN is explicitly defined. Besides the
structured information represented in the DIN, we find that
the unstructured information is useful for similar disease
detection. For example, the literature contains rich and latest
research progresses about diseases. The disease taxonomy
(provided by DO) describes the hierarchical relationships
among diseases. The disease annotations (provided by GO)
introduce the functions of related genes. Thus, performing
similarity analysis on the unstructured information can pro-
vide an extra contribution to similar disease detection.
As stated above, we can see that the unstructured in-
formation is multimodal. Multimodal-information has mul-
tiple types of information, providing different perspectives
to describe the relevance between diseases. Thus, it is un-
reasonable to adopt a unified similarity measure. Instead,
we propose an integrative approach to detect similar dis-
IEEE TCBB 2
eases. Specifically, we first construct the DIN using struc-
tured information and compute the disease similarities.
Secondly, we evaluate the disease similarities on each type
of multimodal-information. Finally, similar diseases are de-
tected by integrating similarities.
Technically, there are two challenges.
- How to design the similar measure for each type of
multimodal-information?
- How to integrate disease similarities under different
information scales?
To address these challenges, we propose a DIN-based in-
tegrative approach, named MISSION (short for multimodal-
information-aided similar disease detection), to perform
top-k similar disease query for a given disease. Briefly, MIS-
SION starts with constructing the DIN which contains four
entities (i.e., disease, phenotype, gene, and chemical) and
the relationships among them. The DIN-based similarity is
evaluated based on the meta structure connecting the query
diseases. Next, for the multimodal-information, MISSION
computes the similarity with each type of multimodal-
information independently, and combines the results to-
gether. Finally, MISSION adopts the multimodal compact
bilinear pooling to integrate the DIN-based similarity and
multimodal-information-based similarity.
In summary, the main contributions of this work are as
follows:
• We propose a DIN-based integrative approach MIS-
SION to detect similar diseases. MISSION not
only takes DIN-based similarity into considera-
tion, but also can evaluate disease similarity from
multimodal-information.
• We design similarity measures for disease taxonomy,
disease attributes, disease literature, and disease an-
notations information, respectively, as well as an
approach for similarity integration.
• We conduct extensive experiments using real-world
datasets to demonstrate the effectiveness of MIS-
SION for similar disease detection from multimodal-
information.
A preliminary version of this work appeared in the pro-
ceedings of the IEEE BIBM 2020 conference [12]. Compared
to that work, we made several major improvements. First,
we incorporate another type of multimodal-information,
i.e., disease annotations, to measure the relationships be-
tween diseases more comprehensively. Second, we optimize
the interaction strategy between the disease information
network and auxiliary multimodal-information. Third, we
add an analysis of the works related to disease informa-
tion retrieval. Finally, we conduct more extensive empirical
evaluations: (1) adding more evaluation indicators in perfor-
mance comparison; (2) performing a more detailed analysis
of MISSION variants; (3) testing parameter sensitivity; and
(4) providing an extra case study about top-k similar disease
query.
The remainder of the paper is organized as follows. We
briefly discuss the related works in Section 2. Section 3
introduces the architecture of MISSION, followed by exper-
iments and results discussed in Section 4. In Section 5, we
conclude our work and highlight the future directions.
2 RELATED WORK
2.1 Disease Similarity Analysis
With available data increasing, many studies about disease
similarity analysis were carried out, which advance the
development of biology.
Some methods depended on DO to measure the seman-
tic similarity of diseases. DO unifies the representations
of diseases among varied vocabularies into a relational
ontology, in which the term is the professional noun for
referring to each disease. The Information Content (IC),
indicating how specific and informative a term is, has been
widely used for measuring the similarities among terms. For
example, Resnik et al. [13] measured disease similarity based
on the IC of the most informative common ancestor (MICA)
between two terms. Lin et al. [14] incorporated the IC of both
two terms and their MICA. Wang et al. [6] computed the
similarities among terms by considering the contributions
of all common ancestors in the ontology.
Moreover, some studies utilized the relationships be-
tween diseases and genes to detect similar diseases. Mathur
et al. [15] first proposed a method called BOG that calculates
similarity by comparing gene overlaps of related diseases.
However, it does not consider the functional relations be-
tween disease-related genes. Furthermore, Mathur et al. [8]
proposed a process similarity-based (PSB) method involv-
ing the GO biological process terms associated with genes.
However, only relying on disease-related genes greatly
limits the utility of those methods mentioned above. Re-
cently, Qin et al. [10] proposed RADAR, which derives a
multi-layer similarity network from multiple disease as-
sociations, to learn the latent representation of diseases.
Besides, Zhang et al. [16] considered the associations be-
tween diseases and non-coding RNAs, as well as functional
associations and semantic associations between diseases to
discover similar diseases.
Facilitated by disease similarity analysis, other re-
searches were conducted. For example, Lei et al. [17] utilized
the integration of disease semantic similarity and functional
similarity, and adopted the bipartite network projection
method to predict latent metabolite-disease associations.
Moreover, Jarada et al. [18] leveraged disease-related simi-
larity information, and combined the drug-related similarity
information and the known drug-disease interaction infor-
mation to predict drug-disease relationships.
It can be seen that various information is employed to
analyze similar diseases. However, existing disease similar-
ity analysis methods almost focus on one type of informa-
tion, without a comprehensive description of the relation-
ships among diseases.
2.2 Disease Information Retrieval
Information retrieval is an essential part of similar disease
detection. Different types of disease information character-
ize disease features in different ways. Disease information
retrieval can be divided into three main categories: the
taxonomy information, the association information, and the
literature information.
Some studies retrieved taxonomy information from dis-
ease terminologies, such as DO and the Human Phenotype
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Ontology (HPO) [19]. For example, Cheng et al. [20] devel-
oped an online system, called DisSim, to explore significant
similar diseases by measuring the similarities among DO
terms. Moreover, in SemFunSim [11], DO was also used as
a part to detect similar diseases. Besides, the information
of HPO was employed for disease classification in Medical
Subject Headings (MeSH) [21].
Some studies retrieved association information by build-
ing information networks. Specifically, Suthram et al. [22]
proposed a quantitative framework to compare and contrast
diseases by analyzing disease-related mRNA expression
data and the human protein interaction network. Besides,
Deng et al. [23] proposed a method MultiSourcDSim that
integrates multiple disease similarity networks established
based on disease associations to calculate disease similarity.
In addition, the clinical medical literature can provide
detailed information about diseases, especially for new dis-
eases. Kim et al. [24] proposed a literature-based method,
called LDDSim, to estimate disease similarity. LDDSim
uses all possible gene symbols and drug names in litera-
ture to characterize diseases and calculates feature values
of diseases with the frequencies of co-occurrence of the
two entities. Besides, Kafkas et al. [25] formed a database
of pathogen and its phenotypes by extracting pathogen-
disease relations from literature. What’s more, Li et al. [26]
presented a method to measure disease similarity, called
MedNetSim, in which biomedical literature mining plays an
important role.
Although many types of information describe diseases
from different aspects, unfortunately, not all types of infor-
mation are integrated to measure similar diseases.
3 OUR SOLUTION – MISSION
In this section, we present the detailed techniques used in
MISSION. Figure 1 shows the framework of MISSION.
3.1 Disease Information Network based Similarity
In order to effectively calculate the similarities among dis-
eases, we employ the disease information network, which
is a typical heterogeneous information network, to model
disease associations.
Definition 1 (Disease Information Network). A disease
information network (DIN) is defined as an undirected
graph G = (V,E), in which V and E are the sets
of nodes and edges between nodes, respectively. G is
associated with a node type mapping φ : V → A and
an edge type mapping ψ : E → R, where A refers to
the type set of disease-related entities and R denotes the
type set of all relations.
For the construction of DIN, we adopt the method
of [27]. Please refer to [27] for the details of the process
of building a disease information network, considering that
this is not the focus of our study.
After constructing DIN, a critical point is to capture
complex semantic relationships among diseases on DIN
for calculating the similarities among diseases. Note that
there are many approaches for disease similarity measure-
ment (e.g., [28]), without depending on a specific similarity
metric. Here, we adopt the meta structure, which has a
strong ability to express complex relationships between two
diseases [29].
Definition 2 (Disease Meta Structure). Given a DIN G =
(V,E), a disease meta structure M = (V, E , di, dj) is a
sub-graph where V ⊆ V is a set of nodes and E ⊆ E is a
set of edges. The meta structure M is a directed acyclic
graph with a source disease node di and a target disease
node dj .
Then we denote M = {M1,M2, ...,Mn} as the set of
meta structures between diseases di and dj . We also define
disease meta structure instance set between diseases di and dj
as Insdi→dj (M), which is a set of sub-graphs going from
di to dj induced by M . Please note that we design four
meta structures based on DIN to express different relevance
between two diseases, as illustrated in Figure 3.
Example 1. An example of disease information network is il-
lustrated in Figure 2. There are a total of four node types
(i.e., disease, gene, phenotype, and chemical). Figure 3
shows four designed meta structures. The corresponding
multiple disease meta structure instances can be found in
this disease information network. For example, the meta
structure M2 indicates that two diseases are associated
with the same chemical. In addition, they have the same
symptom at the same time. And, the corresponding two
disease meta structure instances, i.e., “d5-{c3, p2}-d2”
and “d5-{c5, p2}-d3” are shown in the shaded part of
Figure 2.
Observation 1. In a disease information network, the more
disease meta structure instances shared by two diseases,
the more similar they are.
Example 2. In Figure 2, two diseases d1 and d4 share two
disease meta structure instances, i.e., “d1-{g1, p1}-d4”
and “d1-{g2, p1}-d4”, while two diseases d1 and d2 have
only one disease meta structure instance, i.e., “d1-{g2,
p3}-d2”. It can be seen that the relevance between d1 and
d2 is weaker than the relevance between d1 and d4. In
other words, d4 is more similar to d1 compared with d2
to d1.
Based on Observation 1, given a meta structure, we
consider the similarity between any two diseases through
the shared disease meta structure instances. Formally, given
a DIN, the similarity between two diseases di and dj based
on the meta structure M can be defined as:
MetaSimM (di, dj) = |Insdi→dj (M)|, (1)
where the value of |Insdi→dj (M)| is the number of in-
stances induced by meta structure M .
Typically, there may exist multiple different meta struc-
tures between two diseases. However, for many meta struc-
tures, the disease meta structure instances between two
diseases appear less frequently. With the loss of generality,
we choose the meta structure with the most disease meta
structure instances to represent the relationships between
two diseases. Thus, we calculate the similarity between two
diseases based on DIN as:
NetSim(di, dj) = max
M∈M
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Fig. 2. An example of disease information network.
3.2 Multimodal-Information based Similarity
In this section, we mainly focus on four types of
multimodal-information, including the disease taxonomy,
disease attributes, disease literature, and disease annota-
tions. Note that, the disease taxonomy and disease attributes
both come from DO database [7]. Disease literature is ex-
tracted from PubMed1. Disease annotations are obtained
from GO database [9].
3.2.1 Disease Taxonomy Similarity
In DO database, diseases are linked into a hierarchical struc-
ture by a type of semantic relation, called ‘IS A’ relation.
We call such a hierarchical structure disease taxonomy tree,
defined as:
Definition 3 (Disease Taxonomy Tree). A disease taxonomy
tree (DT) is a polytree, which is a directed acyclic graph
defined as T = (D, E). D is the set of disease nodes, and
E is the set of edges that represent the ‘IS A’ semantic
relation between diseases.
Then, we define the similarity between two diseases
based on the disease taxonomy tree. As stated in [6], the
similarity between two disease nodes di and dj can be calcu-










Fig. 3. The illustration of four meta structures.
in the disease taxonomy tree. Let the set of ancestors of
disease d be Nd. The semantic contribution of an ancestor
t ∈ Nd to disease d is Sd(t), defined as:
Sd(t) =
{
1 t = d
max{w · Sd(t′)|t′ ∈ children of t} t 6= d
,
(3)
where node t′ is a child of node t, and w represents the
semantic contribution factor of ancestor t to t′ and is set to
0.5 according to [6].
Thus, given two diseases di and dj , their similarity based














Sdi(t) is the summation of all the contributions
of Ndi to disease di.
3.2.2 Disease Attribute Similarity
In addition to the hierarchical structure, DO also includes
meta-data in the form of attributes. The meta-data can
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provide abundant valuable information about diseases, and
thus can be applied to analyze the similarities among dis-
eases. Please note that some attributes among the meta-data
are trivial due to many missing data. For better analysis, we
select five attributes with less missing data, including name,
def, synonym, created by, and creation date.
Next, it is required to comprehensively utilize multiple
kinds of attribute information to characterize diseases. Here,
we use Word2Vec [30], which is widely adopted to generate
vector representation of words through fully considering
the contextual information, to obtain feature vectors of
diseases. Specifically, we first build an attribute corpora by
generating sentences from disease attributes. For example,
if the attribute of a disease di has a synonym s, the sentence
“di synonym s” will be generated. Consequently, we use
the pre-trained Word2Vec model [31] to assign a semantic to
the attribute words (e.g., synonym). Next, the Skip-Gram
model of Word2Vec is applied to retrain the pre-trained
Word2Vec model based on the attribute corpus. Finally, for
each disease d, we get a vector representation Fattd .
Accordingly, the similarity of disease pairs based on
disease attributes can be calculated by utilizing the repre-










3.2.3 Disease Literature Similarity
Disease literature provides the latest rich and diverse infor-
mation about diseases. Therefore, we can construct literature
corpora to measure the similarities among diseases.
For a given disease, we crawl literature from PubMed
website by using the disease name as the keyword to
obtain query results sorted by relevance. Then we select the
abstracts of the top 100 most relevant literature to construct
the literature corpus of this disease. To reduce the noise
in the raw literature, we perform the following prepro-
cessing: (1) performing word segmentation processing; (2)
removing the meaningless characters and words, such as
punctuation marks and pronouns; (3) leveraging a Python
package, WordNetLemmatizer, to transform several forms
(e.g., tense) of a word into the dictionary form of the word.
After constructing literature corpora of all diseases, we
use Latent Dirichlet Allocation (LDA) [32], which is a classi-
cal topic model, to extract hidden topics of literature corpora
in the form of a probability distribution. Given the literature
corpus of the disease d, the disease topic vector F litd can be
generated through the LDA model, where each dimension
in this topic vector represents the probability distribution of
the corresponding topic.
Correspondingly, for two diseases di and dj , their
literature-based similarity calculation can be converted to
the cosine similarity between vector representations of these
two diseases, as follows:
LitSim(di, dj) =
F litdi · F
lit
dj





3.2.4 Disease Annotation Similarity
Since GO terms annotate the functions of genes involved
in the occurrence of diseases, we can utilize GO terms to
understand diseases from the characteristics of Biological
Process (BP), Molecular Function (MF), and Cellular Com-
ponent (CC). With the genes as an intermediate conversion,
each disease is annotated with a set of GO terms. So, we
can use such disease annotations to measure the disease
similarity.
Specifically, we need to calculate the IC value of each GO
term first. Similar to [33], we define the count of the given
GO term as the number of term hyponyms on the ontology
structure. Based on the observation about the topology
structure of GO, the count of GO term only depends on
its child terms. Therefore, when the count of leaf terms is
set to 1, the count of non-leaf terms can be calculated by
recursively adding the count of children from bottom to top
in the hierarchical structure, and given by:
f(x) =

1 if x is a leaf term,∑
z∈Ch(x)
f(z) otherwise, (7)
where Ch(x) is the set of children of GO term x in the
hierarchical structure of GO.
Consequently, the IC value of a term can be quantified
as a function of the count of its hyponyms, denoted by:
IC(x) = − lg(f(x)
f(r)
), (8)
where f(r) is the count of root term in the ontology under
consideration.
Based on the above calculation, each GO term is asso-
ciated with its corresponding IC value. As each disease is
annotated by a set of GO terms Od, we can represent the
feature vector of each disease by IC values of GO terms.
Specifically, given a set of diseases D, we denote the feature
vector of a disease di ∈ D with respect to another disease
dj ∈ D\di asFanndi = [v1, v2, ..., vm], wherem = |Odi∪Odj |,
and each vi corresponding to a GO term oi ∈ Odi ∪ Odj is
calculated by Equation 9.
vi =
{
IC(o) if o ∈ Odi ,
0 otherwise.
(9)
Subsequently, the similarity between two diseases di and
dj based on disease annotations can be calculated by Fanndi










By performing the above similarity metrics for any
two diseases, we can obtain four disease similarity ma-
trices based on different types of multimodal-information.
Since the distributions of similarity scores under different
modalities are uneven, it is unreasonable to fuse the raw
similarity scores. Thus, we perform normalization on each
similarity matrix to adjust the distribution of values, en-
abling a balanced fusion of disease similarity features across
multimodal-information. Without the loss of generalization,
we employ the Hadamard product to obtain the similarity
feature of multimodal-information, denoted by:
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InfoSim(di, dj) =TreeSim(di, dj) ∗AttSim(di, dj)
∗ LitSim(di, dj) ∗AnnSim(di, dj).
(11)
Note that, we set the weight of each type of multimodal-
information as 1.0 by default.
3.3 Similar Disease Query
In this section, we introduce how to interact the similarity
feature based on DIN with the similarity feature based on
multimodal-information for a similar disease query. Here,
we adopt the idea of multimodal compact bilinear pool-
ing [34].
According to Equations 2 and 11, for each disease d ∈ D,
we calculate the similarity based on DIN and the similarity
based on multimodal-information with respect to another
diseases. In this case, we get two n-dimensional feature
vectors of this disease, the similarity feature vector based on
DIN vdin and the similarity feature based on multimodal-
information vinfo, where n is the number of diseases. Rely-
ing on Count Sketch [35] projection function Ψ, each feature
vector v ∈ Rn can be projected to y ∈ Rm, where m is the
output dimension. Correspondingly, for feature vectors vdin
and vinfo, we can get the output vectors ydin = Ψ(vdin)
and yinfo = Ψ(vinfo).
As stated in [34], the count sketch of the outer product
of two vectors can be expressed as the convolution of each
individual’s count sketch. Meanwhile, the convolution is
equivalent to the dot product in the frequency domain.
Formally, the output vector of disease d with dimension m
can be obtained by the following formula:
Fd = FFT−1(FFT (ydin) FFT (yinfo)). (12)
By this process, all elements of the two vectors based on
DIN and multimodal-information interact with each other.
In the end, we perform an element-wise signed squared root
normalization.
Ultimately, given two diseases di and dj , we calculate
the similarity between them as:
MSim(di, dj) =
Fdi · Fdj
|| Fdi || || Fdj ||
. (13)
So far, given a set of diseases D and a query disease d ∈
D, the top-k similar disease query can be quickly performed
by calculating the similarity between d and another disease
d′ ∈ D \ (d) based on Equation 13. Algorithm 1 shows the
pseudo-code of top-k similar disease query.
4 EXPERIMENTS AND DISCUSSION
We conduct experiments on real-world datasets to answer
the following questions:
• Q1: How well does MISSION perform compared
with the baselines in detecting similar diseases?
• Q2: Can multimodal-information further improve
the performance in the detection of similar diseases?
• Q3: Does MISSION have the ability to detect similar
diseases even with different levels of information
richness?
Algorithm 1 Top-k Similar Disease Query
Input: d: the given query disease, k: the number of similar
diseases, D: the set of diseases
Output: R: the results of similar disease query
1: R ← ∅
2: S ← ∅
3: vdin ← Obtain the similarity feature of d based on DIN
according to Section 3.1
4: vinfo ← Obtain the similarity feature of d based on
multimodal-information according to Section 3.2
5: Generate Fd according to Equation 12
6: for d
′ ∈ D \ d do
7: v
′
din ← obtain the similarity feature of d
′
based on
DIN according to Section 3.1
8: v
′
info ← obtain the similarity feature of d
′
based on
multimodal-information according to Section 3.2
9: Generate F ′d according to Equation 12
10: Calculate similarity sim according to Equation 13
11: S ← S ∪ {(d′ , sim)}
12: end for
13: Sort S by sim in descending order




Different types of information were collected from various
sources to validate the effectiveness of our proposed MIS-
SION. The followings describe the details of each type of
information.
First, a total of three types of disease associations
were employed to construct the disease information net-
work, i.e., disease-gene associations, disease-chemical asso-
ciations, and disease-phenotype associations, which were
derived from the DisGeNet database [36], Comparative
Toxicogenomics Database (CTD) [37], and HSDN [38], re-
spectively. Besides, the data of terms was downloaded from
DO database [7], containing 162639 disease terms. After
the following two steps: (1) screening the co-occurring
diseases in all the disease associations, and (2) mapping
the various IDs of all diseases to the corresponding ID in
the DO database uniformly through utilizing the mapping
relationships obtained from DisGeNet and DO database,
1754 diseases were finally extracted. The main statistics of
the disease information network are summarized in Table 1.
Then, the abstracts of a total number of 253960 literature
related to 1754 diseases were crawled from PubMed, which
is a free resource supporting the retrieval of biomedical
and life science literature. In addition, GO database [9]
provided GO terms, and the annotation relationships of GO
terms to genes were obtained from Gene Ontology Anno-
tation (GOA) database [39]. Then, by taking the disease-
gene associations obtained from the DisGeNet [36] database
as intermediate conversions, the annotation relationships
between 1754 diseases and 17920 GO terms were obtained.
4.1.2 Evaluation Metric
To evaluate MISSION quantitatively, the widely used metric
AUC, which is defined as the area under the receiver oper-
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TABLE 1
Statistics of the Disease Information Network













ating characteristic (ROC) curve enclosed by the coordinate
axis, was adopted. Compared with the ROC curve, AUC
can more clearly indicate which method performs better.
And, the higher the AUC score, the better the performance.
Besides, the benchmark set we used was integrated from
two manually checked datasets of disease pairs, one ob-
tained from the study of Suthram et al. [22] and the other
derived from the work of Pakhomov et al. [40]. In total, the
benchmark set contains 47 diseases and 70 disease pairs of
high similarity. Then, the negative sample set, including 200
disease pairs, was randomly generated based on the disease
set by excluding the disease pairs that already exist in the
benchmark set. To weaken the impact of the bias caused by
occasionality, the experiments were repeated 100 times on
the newly generated negative sample set for each time, and
then the average AUC score was calculated to represent the
performance of MISSION.
4.1.3 Comparison Methods
To demonstrate the effectiveness of MISSION, six methods
were considered as baselines, including homogeneous re-
lationship based methods, i.e., Resnik’s [13], Wang’s [6],
Lin’s [14] and PSB [8], as well as heterogeneous relation-
ships based methods, i.e., RADAR [10] and SemFunSim [11],
which are all introduced in Section 2. Moreover, MISSION-
S, a variant of MISSION, was also regarded as a baseline,
which only bases on DIN (i.e., only using disease associ-
ations) without any multimodal-information. This setting
ensures a comprehensive evaluation for the performance of
our proposed method.
4.1.4 Parameter Settings
Generally, the parameters were set according to the default
and optimal experiment effect. According to [31], the pa-
rameters used to retrain the Skip-Gram model were set
as follows: the dimension of the word embedding is 200,
the number of iterations is 100, the minimum count is 1,
and the window is 5. Besides, the number of LDA topics
was set to 85 based on the optimal experimental result.
For each type of variant, to make the optimal output di-
mension m applicable for most variants, we set the output
dimension m of the unimodal-information-aided variants,
bimodal-information-aided variants, trimodal-information-
aided variants and MISSION to 8000, 2000, 1000 and 1000,
respectively.
All experiments were conducted on a PC with an Intel
Xeon E5-2678 v3 2.50 GHz CPU and 64 GB main mem-
ory, running the Ubuntu 19.04. All algorithms were im-
TABLE 2




Resnik’s 0.6933 0.624 0.6528
Wang’s 0.7323 0.6444 0.6908
Lin’s 0.7323 0.6831 0.7057
RADAR 0.9084 0.844 0.8741
PSB 0.9191 0.8634 0.8935
SemFunSim 0.9633 0.8987 0.9354
MISSION-S 0.9407 0.9002 0.9212
MISSION 0.9766 0.9436 0.9627
plemented in Python and compiled by Python 3.7. The
source codes and dataset of MISSION are available on
https://github.com/MangoXu98/MISSION.
4.2 Performance Comparison with Baselines (Q1)
The disease similarity scores among 3525 diseases calcu-
lated by these methods (i.e., Lin’s, Wang’s, Resnik’s, PSB,
and SemFunSim) are prepared in the system DincRNA [41],
which can be downloaded directly. Additionally, the disease
similarity scores calculated by RADAR were obtained by
utilizing the disease associations collected in our work.
Considering the difference between the diseases in DincRNA
and the diseases collected in our work, we picked the
shared diseases from the two disease sets, and 834 common
diseases were finally obtained. Correspondingly, 38 diseases
and 40 disease pairs were extracted from the benchmark set
and new negative sample sets were randomly generated.
Based on this, we verify the effectiveness of MISSION from
two aspects as follows.
First, we compared the performance of MISSION with
baselines based on the AUC score. The comparison results
are reported in Table 2, from which we can observe that our
proposed method MISSION achieves the best performance,
indicating the effectiveness and accuracy of MISSION in
detecting similar diseases. Furthermore, the remaining find-
ings are summarized as follows: (1) Although MISSION-
S outperforms most baselines, it fails to exceed SemFun-
Sim that simultaneously leverages disease associations and
taxonomy. This finding indicates that considering multi-
ple types of information is necessary, which also validates
our motivation of incorporating multimodal-information.
(2) Based on DIN, both RADAR and MISSION-S produce
good results. But in contrast, RADAR is slightly inferior to
MISSION-S, showing the superiority of meta structure in
mining the network structure. (3) Most homogeneous rela-
tionship based methods, i.e., Resnik’s, Wang’s, and Lin’s,
perform the worst. The reason may lie in that only one type
of information fails to adequately describe the relationships
between diseases, making these methods unable to iden-
tify similar diseases well. (4) The removal of multimodal-
information of MISSION (i.e., MISSION-S) results in signif-
icant performance degradation, showing the importance of
multimodal-information for performance enhancement.
Next, for further comparison, another experiment was
also carried out. Specifically, given the value of k in the
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Fig. 4. Performance analysis of MISSION compared with (a) baselines, (b) unimodal-information-aided variants, (c) bimodal-information-aided
variants, and (d) trimodal-information-aided variants respectively.
TABLE 3





Max Min Average Max Min Average
- - - - - MISSION-S 0.9407 0.9002 0.9212
Unimodal
L 0.9034 0.8099 0.8504 MISSION-SL 0.969 0.9386 0.9546
A 0.8871 0.8239 0.8553 MISSION-SA 0.9626 0.9309 0.948
T 0.8234 0.74 0.7822 MISSION-ST 0.9506 0.9191 0.9375
O 0.7311 0.6603 0.6947 MISSION-SO 0.9401 0.9018 0.9244
Bimodal
LA 0.9279 0.8604 0.8903 MISSION-SLA 0.9728 0.9431 0.9587
LT 0.9243 0.8473 0.88 MISSION-SLT 0.9739 0.9434 0.9586
LO 0.912 0.8276 0.8624 MISSION-SLO 0.9733 0.9444 0.9585
AT 0.9128 0.8552 0.8833 MISSION-SAT 0.9719 0.94 0.9571
AO 0.8873 0.8268 0.8594 MISSION-SAO 0.9671 0.9356 0.9538
TO 0.8278 0.7429 0.7868 MISSION-STO 0.9534 0.9178 0.939
Trimodal
LAT 0.9431 0.8798 0.9063 MISSION-SLAT 0.9769 0.943 0.9629
LAO 0.9313 0.8675 0.8942 MISSION-SLAO 0.9774 0.9435 0.9626
LTO 0.928 0.8531 0.8833 MISSION-SLTO 0.9763 0.9423 0.9622
ATO 0.9059 0.843 0.8759 MISSION-SATO 0.9739 0.9395 0.9601
- LATO 0.9418 0.8788 0.9061 MISSION 0.9766 0.9436 0.9627
similar disease query, we checked how many disease pairs
in the benchmark set (i.e., answer pairs) can satisfy this
query. For example, for the disease pair (Asthma, Chronic
Obstructive Pulmonary Disease) in the benchmark set, the
ranking of disease Chronic Obstructive Pulmonary Disease
relative to disease Asthma is 1. If the given value of k is 100,
then the number of answer pairs for this top-100 query is
increased by 1, since the relative ranking of (Asthma, Chronic
Obstructive Pulmonary Disease) is within 100.
The experiment results are shown in Figure 4(a), and
we observe that: (1) MISSION consistently outperforms
all baselines (i.e., always finding the more answer pairs
than all baselines), which demonstrates its effectiveness in
performing top-k similar disease query; (2) when k is 200,
MISSION finds nearly 92.5% disease pairs in the benchmark
set, while all baselines cannot; and (3) the performance
of MISSION-S is basically the same as that of SemFunSim,
and the homogeneous relationship based methods perform
worse. Overall, the performance of all methods is roughly
consistent with the results based on the AUC score.
4.3 Performance Comparison with Variants (Q2)
In order to further explore the enhancement effect of differ-
ent combinations of each type of multimodal-information
on DIN for similar disease detection, a detailed compar-
ative analysis was carried out. To be specific, by utiliz-
ing each type of multimodal-information as supplemen-
tary information, three types of variants of MISSION were
obtained accordingly, including (1) unimodal-information-
aided variants: only one type of multimodal-information
was adopted, and 4 variants were produced, (2) bimodal-
information-aided variants: 6 variants were generated by
combining the two types of multimodal-information in
pairs, and (3) trimodal-information-aided variants: three
types of multimodal-information were combined simulta-
neously, and the corresponding 4 variants were obtained.
Similar to Section 4.2, the results were analyzed from two
aspects.
Each type of multimodal-information is represented by
a capital letter, namely S stands for disease associations,
L for disease literature, A for disease annotations, T for
disease attributes, and O for disease taxonomy. Besides, the
connected letters indicate that the corresponding type of
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Fig. 5. Performance analysis of different variants with respect to parameter m, namely (a) unimodal-information-aided variants, (b) bimodal-
information-aided variants, (c) trimodal-information-aided variants, and (d) multimodal-information-aided variants (i.e., MISSION).
multimodal-information is adopted simultaneously. For ex-
ample, LA means that both disease literature and annotation
are utilized to measure disease similarity, and MISSION-
SLA represents that disease literature and annotations serve
as supplementary information for the disease information
network at the same time. The experimental results of each
variant divided by type are presented in Table 3, in which
the best and second-best results are highlighted in bold and
underline.
First, it can be seen that the average AUC scores based on
each type of multimodal-information (i.e., L (only using dis-
ease literature), A (only using disease annotations), T (only
using disease attributes) and O (only using disease taxon-
omy)) are 0.8504, 0.8553, 0.7822 and 0.6947, respectively,
while the average AUC score of MISSION-S (only using
disease associations) is 0.9212. This indicates that the disease
associations describe the disease relationships in more detail
than other types of information, that is, only relying on
disease associations can also achieve a good result, which
supports our idea of employing disease associations as a
basis and others as auxiliary multimodal-information. Then,
we hold an independent analysis of each type of variant
below.
Unimodal-Information-Aided Variants. By adding each type
of multimodal-information individually as supplementary
information, the performance of unimodal-information-
aided variants is improved to varying degrees in compar-
ison with MISSION-S. Among the multimodal-information,
it can be seen that the variant aided by disease literature
performs best, while the enhancement effect of disease
taxonomy is the worst. The reason is that disease taxonomy
can only provide a few supplementary information about
disease classification. Notably, although the AUC score of
L is slightly lower than that of A, the variant MISSION-SL
achieves a better performance than MISSION-SA. In other
words, for DIN, disease literature contributes more supple-
mentary information than disease annotations. This is also
in line with our expectations because literature provides
more supplementary information in the form of text (e.g.,
up-to-date disease information).
Bimodal-Information-Aided Variants. By adding another
type of multimodal-information to each of the unimodal-
information-aided variants, each variant achieves better
performance. The variants aided with the combination of
disease literature and another single type of multimodal-
information have almost the same performance. Perhaps,
this is because another type of multimodal-information con-
tributes little useful information to the variant MISSION-
SL. Moreover, when incorporating the disease taxonomy,
only a slight performance improvement is observed in either
auxiliary bimodal-information or variants. This is probably
because little valuable information was provided by the
disease taxonomy.
Trimodal-Information-Aided Variants. When adopting three
types of multimodal-information at the same time, there
is a general performance improvement for all trimodal-
information-aided variants and the performance gap is nar-
rowed. This also demonstrates that it is effective to adopt
various types of multimodal-information to enhance DIN
in similar disease detection. A further novel finding is that
compared with MISSION-SLAT, the performance of MIS-
SION decreases slightly with the addition of disease taxon-
omy. The reason might be that the information contained
in MISSION-SLAT is already abundant, and considering
disease taxonomy with a low confidence level introduce
external noise instead.
Next, the experiment results of checking how many
disease pairs satisfy the similar disease query for the given
value of k are presented in Figure 4(b)(c)(d). Obviously,
MISSION performs better than most of its variants, and
variants with more types of multimodal-information gen-
erally have better performance than those with fewer types
of multimodal-information. Moreover, when the number of
types are more than one, the performance of variants is
roughly close to that of MISSION. However, MISSION per-
forms slightly worse than a few variants when k is 100. This
is probably because MISSION raises the ranking of some
disease pairs (e.g., disease subtypes) that are not recorded
in the benchmark set but of highly similar, therefore lowing
the ranking of corresponding disease pairs in the benchmark
set.
4.4 Parameter Sensitivity
Here, we investigated how the output dimension m affects
the performance of the model. And, the performances of
each type of variant with changing the output dimension m
are presented in Figure 5.
As can be seen from Figure 5(a), the performances of the
unimodal-information-aid variants do not fluctuate much
and the best results are generally achieved when m reaches
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8000. As shown in Figure 5(b), the AUC scores of the
bimodal-information-aid variants have very little difference
and generally perform best when m is 2000. Besides, for
the trimodal-information-aid variants and MISSION, when
the dimension m exceeds 1000, the performance shows a
downward trend, and the best performance is achieved
when m is 1000 as presented in Figure 5(c) and Figure 5(d).
Overall, the performance trends of the same type of
variants along the dimension are similar. Moreover, our
method MISSION is not critically sensitive to the output
dimension m with a small performance fluctuation.
4.5 Case Study (Q3)
Two case studies were carried out: (1) top-k similar disease
query; and (2) similar disease detection with different infor-
mation richness.
4.5.1 Similar Disease Query
Five diseases, i.e., Familial Combined Hyperlipidemia, Sclero-
derm, Alzheimer’s Disease, Asthm and Bronchiti were ran-
domly selected from the benchmark disease set as the
target diseases to perform top-k similar disease query. We
retrieved the corresponding top-3 similar diseases based on
MISSION. The query results are reported in Table 4. In
general, all the top-3 diseases are strongly related to the
given query disease, especially for Alzheimer’s Disease that
the most relevant diseases are all its subtypes. For diseases
Asthm and Bronchiti, the most similar diseases are Chronic
Obstructive Pulmonary Disease and Pneumoni respectively,
which are recorded in benchmark set. Besides, for disease
Scleroderm, the most relevant disease Systemic Scleroderma is
one of its forms. Moreover, the most similar disease for Fa-
milial Combined Hyperlipidemia is Abdominal Obesity-metabolic
Syndrome 1. Although this disease pair does not exist in the
benchmark set, some studies have indicated that Familial
Combined Hyperlipidemia develops against a background of
Abdominal Obesity [42].
TABLE 5
The Ranking of Disease Pairs in Each Stage
Disease Pair
Ranking
Stage 1 Stage 2 Stage 3
(Leukopenia, Pneumonia) 102 17 5













4.5.2 Similar Disease Detection with Different Information
Richness
Based on the process of disease research, we divided in-
formation into the three stages to detect similar diseases
according to the different degree of information richness,
as follows: (1) Stage 1: only disease-phenotype associations
were obtained through clinical when appearing a new dis-
ease; (2) Stage 2: with in-depth research, extensive literature
recording the latest research was published. Besides, some
disease annotations and associations with other entities
were discovered; (3) Stage 3: the DO and more disease
associations were established and enriched.
Five disease pairs were selected from the benchmark set
for research, i.e., (Leukopenia, Pneumonia), (Cataract, Pancreati-
tis), (Asthma, Chronic Obstructive Pulmonary Disease), (Chronic
Progressive External Ophthalmoplegia, Dilated Cardiomyopathy),
(Myocardial Infarction, Chronic Obstructive Pulmonary Disease).
The information corresponding to the above three stages
was specified as follows: disease-phenotype associations
(Stage 1), the disease associations with phenotypes and
genes, disease annotations and literature (Stage 2), and all
information (Stage 3).
The ranking results of disease pairs in each stage are
presented in Table 5, in which this ranking refers to the
relevance ranking of the second disease to the first one.
Overall, MISSION can perform the similar disease query
in all the three stages with different information richness,
although the result is different. Furthermore, we observe
that: (1) all the five target disease pairs are generally low-
ranking in the first stage; (2) in the second and third stage,
when more information is incorporated, the ranking of
disease pairs increases accordingly, which is also in line
with our expectations; (3) for some diseases, the most similar
diseases can be found only by providing partial information.
Take the disease pair (Asthma, Chronic Obstructive Pulmonary
Disease) as an example, the similarity ranking is already 1
in the second stage. Nonetheless, for most diseases, more
information is needed to be considered, and MISSION can
meet the needs for mining similar diseases from a large
amount of information.
To sum up, MISSION gains performance improvement
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accordingly as more types of information are available. And,
MISSION is able to detect similar diseases in various stages
with different information richness of disease research.
4.6 Efficiency Analysis
We further performed an efficiency analysis of similarity
measurement based on each type of information by ran-
domly choosing 20, 40, 60, 80, 100 percent diseases in the
dataset respectively.
As shown in Figure 6, the runtime increases with the
number of diseases, although the growth rate differs from
one another. Besides, the runtime of similarity measurement
based on disease annotations (i.e., A) grows fast relatively,
and the runtime of some types of information reaches 103 s
when all diseases are adopted. Fortunately, they can work
in parallel due to mutual independence, reducing the total
time-cost of MISSION. Furthermore, the calculation results
of each type of information can be saved offline, so that the
subsequent similar disease query can be quickly performed.












S L A T O
Fig. 6. Runtime w.r.t. the number of diseases.
5 CONCLUSION
Similar disease discovery can deepen our understanding
of the field of bioinformatics. In order to flexibly integrate
multiple types of information to comprehensively describe
the characteristics of diseases, we propose a novel approach,
MISSION, to perform the top-k similar disease query based
on the integrative information. MISSION considers multiple
types of disease-related information, i.e., disease taxonomy,
attributes, literature and annotations, to enhance the disease
information network, thereby providing a more reliable
description of the relevance between diseases. Extensive
experimental results on the real-world datasets suggest that
MISSION outperforms all baselines, demonstrating its supe-
riority. Besides, the performance comparison with variants
confirms our idea of incorporating multimodal-information
is helpful. Meanwhile, we further validate the effectiveness
of MISSION in the two relevant case studies.
For future work, we intend to focus on the following
tasks. First, we will look for a suitable method to au-
tomatically discover meaningful meta structures from the
disease information network, without requiring domain ex-
pert knowledge to design manually. Besides, more types of
information (e.g., electronic health records data) can be con-
sidered to further improve the accuracy of similar disease
detection. Moreover, it would be interesting to explore the
contribution rate of each type of multimodal-information to
MISSION.
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